Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial
Megan E Jensen, Genevieve Mailhot, Nathalie Alos, Elizabeth Rousseau, John H White, Ali Khamessan, Francine M Ducharme, Megan E Jensen, Genevieve Mailhot, Nathalie Alos, Elizabeth Rousseau, John H White, Ali Khamessan, Francine M Ducharme
Abstract
Background: Trials in school-aged children suggest vitamin D supplementation reduces asthma exacerbations. Primary aim: to examine whether vitamin D3 (100,000 IU) rapidly raises serum 25-hydroxyvitamin D (25OHD) ≥75 nmol/L in asthmatic preschoolers.
Methods: In a double-blind, randomised, placebo-controlled trial, preschool-aged children with asthma received 100,000 IU vitamin D3 (intervention) or placebo (control), followed by 400 IU vitamin D3 daily for 6 months. Serum 25OHD was measured at baseline, 10 days, 3 and 6 months. Outcomes included the group difference in 25OHD change from baseline at 3 months (Δ25OHD); the proportion of children with 25OHD ≥75 nmol/L at 3 months; the pattern in serum vitamin D over 6 months; the proportion of children with hypercalciuria at any time point (safety); and group rates for oral corticosteroids. Continuous outcomes were analysed using generalised linear mixed models and group rate ratios of events per child were assessed using a Poisson distribution model.
Results: Twenty-two children were randomised (intervention:11; control:11) during winter. At 3 months, the group difference in Δ25OHD (7.2 nmol/L; 95 % CI: -13.7, 28.1) was not significant; yet, 100 % versus 54.5 % (intervention versus control) had serum 25OHD ≥75 nmol/L. There was a significant group difference in Δ25OHD at 10 days (110.3 nmol/L; 95 % CI: 64.0, 156.6). One child in each group had transient hypercalciuria at 10 days. Group oral corticosteroids rates were 0.82 and 1.18/child, intervention versus control (rate ratio = 0.68; 95 % CI: 0.30, 1.62; non-significant).
Conclusions: Following 100,000 IU vitamin D3, all children reached serum 25OHD ≥75 nmol/L, compared with half who received placebo. Daily supplementation, sun exposure and insufficient power may explain the absence of a significant 3-month group difference in Δ25OHD. No clinically important alterations in bone metabolism biomarkers occurred. Group oral corticosteroid rates will inform sample size calculations for the larger trial. ( NCT01999907 , 25 November 2013).
Keywords: Asthma; Child; Diet; Feasibility study; Paediatric; Randomised controlled trial; Vitamin D.
References
- Rosychuk RJ, Voaklander DC, Klassen TP, Senthilselvan A, Marrie TJ, Rowe BH. Asthma presentations by children to emergency departments in a Canadian province: a population-based study. Pediatr Pulmonol. 2010;45:985–92. doi: 10.1002/ppul.21281.
- Lougheed MD, Garvey N, Chapman KR, Cicutto L, Dales R, Day AG, et al. The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest. 2006;129:909–17. doi: 10.1378/chest.129.4.909.
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2014. . Accessed 20 Dec 2014.
- Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995;332:133–8. doi: 10.1056/NEJM199501193320301.
- Xepapadaki P, Papadopoulos NG. Childhood asthma and infection: virus-induced exacerbations as determinants and modifiers. Eur Respir J. 2010;36:438–45. doi: 10.1183/09031936.00149009.
- Bacharier LB, Phillips BR, Zeiger RS, Szefler SJ, Martinez FD, Lemanske RF, Jr, et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol. 2008;122:1127–35. doi: 10.1016/j.jaci.2008.09.029.
- Ducharme FM, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med. 2009;360:339–53. doi: 10.1056/NEJMoa0808907.
- Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics. 2009;123:e519–25. doi: 10.1542/peds.2008-2867.
- Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze. Lancet. 2014;383:1593–604. doi: 10.1016/S0140-6736(14)60615-2.
- Gupta A, Sjoukes A, Richards D, Banya W, Hawrylowicz C, Bush A, et al. Relationship between serum vitamin D, disease severity and airway remodeling in children with asthma. Am J Respir Crit Care Med. 2011;184:1342–9. doi: 10.1164/rccm.201107-1239OC.
- Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010;126:52–8. doi: 10.1016/j.jaci.2010.03.043.
- Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DYM. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol. 2010;125:995–1000. doi: 10.1016/j.jaci.2010.03.008.
- Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin Infect Dis. 2013;57:392–7. doi: 10.1093/cid/cit289.
- Majak P, Olszoweic-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol. 2011;127:1294–6. doi: 10.1016/j.jaci.2010.12.016.
- Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91:1255–60. doi: 10.3945/ajcn.2009.29094.
- Yadav M, Mittal K. Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian J Pediatr. 2014;81:650–4. doi: 10.1007/s12098-013-1268-4.
- Holick MF. Vitamin D: a D-Lightful health perspective. Nutr Rev. 2008;66:S182–94. doi: 10.1111/j.1753-4887.2008.00104.x.
- Godel JC, Canadian Paediatric Society, First Nations, Inuit and Metis Health Committee Vitamin D supplementation: recommendations for Canadian mothers and infants. Paediatr Child Health. 2007;12:583–9.
- Ducharme FM, Dell S, Radhakrishnan D, Grad R, Watson WM, Yang CM, et al. Diagnosis and management of asthma in preschoolers: a Canadian Thoracic Society and Canadian Pediatric Society position paper. Can Respir J. 2015;22:135–43. doi: 10.1155/2015/101572.
- Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermat. 1988;124:869–71. doi: 10.1001/archderm.1988.01670060015008.
- Ducharme FM, Davis GM, Noya F, Rich H, Ernst P. The Asthma Quiz for Kidz: a validated tool to appreciate the level of asthma control in children. Can Respir J. 2004;11:541–6. doi: 10.1155/2004/783740.
- van den Ouweland JM, Vogeser M, Bacher S. Vitamin D and metabolites measurement by tandem mass spectrometry. Rev Endocr Metab Disord. 2013;14:159–84. doi: 10.1007/s11154-013-9241-0.
- Raymond F, Carbonneau J, Boucher N, Robitaille L, Boisvert S, Wu WK, et al. Comparison of automated microarray detection with real-time PCR assays for detection of respiratory viruses in specimens obtained from children. J Clin Microbiol. 2009;47:743–50. doi: 10.1128/JCM.01297-08.
- Jacobs B. The Canadian Acute Respiratory Illness and Flu Scale (CARIFS): the design and assessment of a paediatric disease severity measure. (Thesis) Toronto: Toronto: University of Toronto; 1999.
- Ducharme FM, Jensen ME, Mendelson M, Parkin P, Desplats E, Zhang X, et al. Asthma Flare-up Diary for Young Children (ADYC) to monitor severity of exacerbations. J Allergy Clin Immunol. 2016;137:744–9. doi: 10.1016/j.jaci.2015.07.028.
- Jensen ME, Mendelson MJ, Desplats E, Zhang X, Platt R, Ducharme FM. Caregiver’s functional status during a young child’s asthma exacerbation: a validated instrument. J Allergy Clin Immunol. 2016;137:782–8. doi: 10.1016/j.jaci.2015.08.031.
- Metz MP. Determining urinary calcium/creatinine cut-offs for the paediatric population using published data. Ann Clinic Biochem. 2006;43:398–401. doi: 10.1258/000456306778520106.
- Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a caliper database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem. 2012;58:854–68. doi: 10.1373/clinchem.2011.177741.
- Gallo S, Comeau K, Vanstone C, Agellon S, Sharma A, Jones G, et al. Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy, breastfed infants: a randomized trial. JAMA. 2013;309:1785–92. doi: 10.1001/jama.2013.3404.
- IOM (Institute of Medicine). Dietary reference intakes for calcium and vitamin D. Washington DC: The National Academies Press; 2011.
- Zeghoud F, Ben-Mekhbi H, Djeghri N, Garabédian M. Vitamin D prophylaxis during infancy: comparison of the long-term effects of three intermittent doses (15, 5, or 2.5 mg) on 25-hydroxyvitamin D concentrations. Am J Clin Nutr. 1994;60:393–6.
- Mallet E, Philippe F, Castanet M, Basuyau JP. Administration of a single winter oral dose of 200,000 IU of vitamin D3 in adolescents in Normandy: evaluation of the safety and vitamin D status obtained. Arch Pediatr. 2010;17:1042–6. doi: 10.1016/j.arcped.2010.04.013.
- Oliveri B, Cassinelli H, Mautalen C, Ayala M. Vitamin D prophylaxis in children with a single dose of 150000 IU of vitamin D. Eur J Clin Nutr. 1996;50:807–10.
- Arpadi SM, McMahon D, Abrams EJ, Bamji M, Purswani M, Engelson ES, et al. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics. 2009;123:e121–6. doi: 10.1542/peds.2008-0176.
- Manaseki-Holland S, Maroof Z, Bruce J, Mughal MZ, Masher MI, Bhutta ZA, et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet. 2012;379:1419–27. doi: 10.1016/S0140-6736(11)61650-4.
- Manaseki-Holland S, Qader G, Isaq Masher M, Bruce J, Zulf Mughal M, Chandramohan D, et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health. 2010;15:1148–55. doi: 10.1111/j.1365-3156.2010.02578.x.
- Tau C, Ciriani V, Scaiola E, Acuna M. Twice single doses of 100,000 IU of vitamin D in winter is adequate and safe for prevention of vitamin D deficiency in healthy children from Ushuaia, Tierra del Fuego, Argentina. J Steroid Biochem Mol Bio. 2007;103:651–4. doi: 10.1016/j.jsbmb.2006.12.027.
- Vidailhet M, Mallet E, Bocquet A, Bresson JL, Briend A, Chouraqui JP, et al. Vitamin D: still a topical matter in children and adolescents. A position paper by the Committee on Nutrition of the French Society of Paediatrics. Arch Pediatr. 2012;19:316–28. doi: 10.1016/j.arcped.2011.12.015.
- Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909–12. doi: 10.4049/jimmunol.173.5.2909.
- Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunol. 2011;134:123–39. doi: 10.1111/j.1365-2567.2011.03482.x.
- Bosse Y, Maghni K, Hudson TJ. 1alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Physiol Genomics. 2007;29:161–8. doi: 10.1152/physiolgenomics.00134.2006.
- Zitterman A, Pilz S, Hoffman H, Marz W. Vitamin D and airway infections: a European perspective. Eur J Med Res. 2016;21:14. doi: 10.1186/s40001-016-0208-y.
- Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res. 2009;29:3675–84.
- Upham JW, Sly PD. Vitamin D in asthma. Is the golden bullet losing its luster? Am J Resp Crit Care Med. 2016;193:598–600. doi: 10.1164/rccm.201511-2213ED.
- Ducharme FM, Morin J, Davis GM, Gingras J, Noya FJ. High physician adherence to phenotype-specific asthma guidelines, but large variability in phenotype assessment in children. Curr Med Res Opin. 2012;28:1561–70. doi: 10.1185/03007995.2012.716031.
- Schultz A, Brand PLP. Episodic viral wheeze and multiple trigger wheeze in preschool children: a useful distinction for clinicians? Paed Respir Rev. 2011;12:160–4.
Source: PubMed